School of Medicine

Showing 1-10 of 14 Results

  • Ronald L. Dalman MD

    Ronald L. Dalman MD

    Walter Clifford Chidester and Elsa Rooney Chidester Professor of Surgery

    Current Research and Scholarly Interests Vascular biology, arterial remodeling, aneurysm development; innovative treatment strategies for AAA, animal models of arterial disease, arterial remodeling and flow changes in spinal cord injury, genetic regulation of arterial aneurysm formation

  • Kristen Davis

    Kristen Davis

    Social Science Research Professional II, Health Services Research Unit

    Bio Kristen Davis, MPH is a Social Science Research Coordinator who has been working at Stanford since 2013, she joined S-SPIRE in March of 2018. She has a background in biology as well as public health. Her interests include health disparities as well as outcomes research. She supports multiple Principal Investigators with their current research as well as assists with the management of federal grant submissions.

  • Vivian de Ruijter

    Vivian de Ruijter

    Instructor, Assistant Director, Stanford-Ucsf Pediatric Device Consortium, Surgery - Pediatric Surgery

    Bio Dr Vivian Emmely de Ruijter is a Stanford University trained physician in healthcare technology innovation. She is a senior manager for Manatt's digital and technology consulting practice, which offers innovative full-service business consulting and legal services, as well as venture capital. Vivian works with healthcare technology and medtech companies to create clinical, regulatory, business and marketing strategies. A medical professional, Vivian leverages her clinical experience to build solutions that advance innovation in healthcare.

    In addition to her current role at Manatt, she serves as the Assistant-Director of the Stanford Pediatric Device Consortium in collaboration with the U.S. FDA. She was also the 2016 Gerhard Grube?s Innovation Fellow at Byers Center of Biodesign at Stanford University after completing her training in hybrid interventional strategies at the IRCAD in France. Dr de Ruijter holds a Doctor of Medicine (MD) degree from The Erasmus University in the Netherlands, a post-doctoral designation in Biodesign, Pediatric Healthcare Technology Innovation, and Surgical Education and Innovation from Stanford University School of Medicine and School of Bioengineering, and completed the Stanford Ignite Program at the Stanford Graduate School of Business, an executive program focused on the fundamentals of business administration. She continues to teach at Stanford University and co-teaches among others MED275B, an undergraduate course in the fundamental principles of Biodesign.

    You may find additional information on Dr de Ruijter's activities and accomplishments through the following websites:

  • Qian Ding

    Qian Ding

    Biostatistician 2, Health Services Research Unit

    Bio Qian works as a Biastatistician at Stanford Surgery Policy Improvement Research & Education (S-SPIRE) Center. She is experienced in analyzing patient outcomes and national surgery-related data sets such as NSQIP, SEER. She participates in consultations with investigators to refine research questions, define hypotheses, design studies and devise analysis plans. Her expertise is implementing data analysis through statistical programming, summarizing findings using tables and figures, and assisting in preparation and submission of abstracts and manuscripts. She is thrilled to be able to contribute to researches that aim to improve public health.

  • Frederick M. Dirbas, MD

    Frederick M. Dirbas, MD

    Associate Professor of Surgery (General Surgery) at the Stanford University Medical Center

    Current Research and Scholarly Interests My research interests are focused on minimizing the impact of breast cancer from a diagnostic and therapuetic standpoint. Breast MRI is a powerful tool to facilitate the screening for and staging of breast cancer, and can be valuable adjunct to guide breast surgery. Oncoplastic surgical techniques optimize cosmesis after breast cancer surgery. Accelerated radiotherapy after lumpectomy decreases radiotherapy treatment times from 6 weeks to just 1 to 5 days.

Footer Links:

Stanford Medicine Resources: